Brief: Alembic Pharmaceuticals Passes Anvisa GMP Audit For API-II Facility
11/12/2024 06:50
Dec 11 (Reuters) - Alembic Pharmaceuticals Ltd
ALEM.NS :
* ALEMBIC PHARMACEUTICALS LTD - PASSES ANVISA GMP AUDIT FOR
API-II
FACILITY
* ALEMBIC PHARMACEUTICALS LTD - COMPLETES ANVISA GMP AUDIT
FOR 8
APIS AT API-II FACILITY
Source text: ID:nBSE4NPfP1
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand